Department of Medicine
-
August 11, 2022
National XLH Day
Vanderbilt recently hosted the National XLH (X-linked hypophosphatemia) Day, and more than 200 patients and families attended. -
August 10, 2022
Burn pit legislation hailed as a victory by physician who became veterans’ advocate
President Joe Biden on Wednesday signed into law a broad expansion of health care benefits for millions of veterans exposed to toxic burn pits, and for Robert Miller, MD, professor of Allergy, Pulmonary and Critical Care Medicine, and his Vanderbilt University Medical Center colleagues, the action is a long-awaited victory. -
August 5, 2022
Study that investigated whether three smoking cessation drugs could reduce alcohol intake yields unexpected finding
A Vanderbilt study of three proven smoking cessation treatments suggests these medications could play an important role to reduce alcohol use and smoking at the same time. -
August 4, 2022
Study shows success at disproving allergies to sulfa antibiotics
A Vanderbilt study shows that physicians can successfully identify and disprove low-risk sulfa antibiotic allergies using an oral antibiotic challenge in consenting patients prior to solid organ transplant. -
August 4, 2022
VUMC lauded for scleroderma treatment, research
Vanderbilt University Medical Center was recently listed as a Designated Scleroderma Research and Treatment Center by the National Scleroderma Foundation. -
August 3, 2022
Embryo screening for mental illness questioned
Report finds polygenic embryo screening (PES) does not provide an accurate measure of the risk of developing psychiatric disorders later in life. -
August 2, 2022
Targeted cancer drug during pregnancy
The targeted cancer therapy alectinib was safe as a treatment for lung cancer during two pregnancies in a patient with non-small cell lung cancer, according to a case report from Vanderbilt physicians.